Analysis of Injection Pen Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Rising acceptance of injection pens for addressing a wide spectrum of medical issues is set to drive their demand across regions. The global injection pen market growth has been forecasted to increase at 7.2% CAGR and reach US$ 93.4 billion by the end of 2034, up from US$ 46.72 billion in 2024.
An increasing number of chronic diseases, increasing incidences of regulatory approvals, and favorable reimbursement policies and government support are resulting in the rising sales of injection pens. Moreover, constant efforts put forward by manufacturers of injection pens for the development of more effective products are set to increase their demand in the coming 10 years.
Injection pens are used as one of the vital medical devices as numerous chronic conditions need frequent administration of medications. Injection pens are used as one of the standard replacements for delivery methodologies for injectable medication. Their growing popularity is attributed to convenience and the ability to be administrated directly by the majority of patients that too without any assistance of a medical professional.
Comparatively pocket-friendly cost of injection pens is estimated to make them easily accessible to patients of different age groups and geographies. The increasing population of geriatric people is set to contribute to the rising demand for injection pens due to immunity deterioration, which results in a growing count of health issues, such as diabetes and cardiovascular diseases. According to the research report published by the International Agency for Research on Cancer, the count of cancer cases and related deaths is increasing around the world, which is generating demand for injection pens.
Adoption of technologically advanced reusable pens is projected to generate lucrative opportunities for suppliers. These newly developed pens are equipped with Bluetooth technology for the calculation of insulin doses, therefore ensuring convenience to respective patients.
| Report Attributes | Details |
|---|---|
| Injection Pen Market Size (2024E) | US$ 46.72 Billion |
| Forecasted Market Value (2034F) | US$ 93.4 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.2% CAGR |
| Market Share of Reusable Injections (2034F) | 62% |
| Japan Market Growth Rate (2024 to 2034) | 2.8% CAGR |
| Western Europe Market Share (2034F) | 16.8% |
| Key Companies Profiled | Novo Nordisk A/S; Sun Pharmaceutical Industries Ltd.; Medtronic plc; Braun Medical; Becton,; Terumo Medical Corporation; Ypsomed AG; Dickinson and Company; Owen Mumford Ltd.; Hoffmann-La Roche Ltd.; Sanofi; AstraZeneca; Merck; Eli Lilly and Company |
“Increasing Number of Health Issues Resulting in High Need for Injection Pens for Medication Authentication”
Increasing population of geriatric people is leading to rising incidences of health issues, due to weaker immune systems. The chances of getting several health disorders, such as diabetes, cardiovascular diseases, etc., increase, which leads to the demand for injection pens to authenticate the dosage used. Further, certain downsides associated with conventional syringes are stimulating more patients to adopt advanced injection pens.
Growing investments in the development of novel medications are increasing the demand for injection pens for the effective administration of medications. In addition, awareness among more patients related to the availability of convenient and novel infection pens is also contributing to their sales.
“Lack of Sufficient Knowledge about Using Injection Pens”
Inadequate guidance and training for the utilization of advanced delivery devices, such as injectable pens, etc., are projected to lead to their inappropriate use, therefore, exposing healthcare personnel and patients to danger. This is adversely impacting demand for injection pens across hospital settings. In addition, injection pens generally carry insulin of different strengths. This is anticipated to increase the risks associated with overdose if the dose is not measured. Growing concerns related to injuries caused due to needles are also hampering the demand for injection pens.
“Development of Injection Pens with Features to Administer Exact Dosage and Improved Memory”
Technological advancements in injection pens are projected to contribute to market growth. New players are expected to invest in technological developments, including offering precise dosage administration and improved memory, which is anticipated to help them secure a position for themselves.
North America is expected to hold 36.7% share of global market revenue by 2034 owing to the rising number of diabetic patients, which are the prominent contributors to market revenue. Further, the regional presence of some key players is also contributing to the injection pen market growth there.
“Popularity of Injection Pens for Medicine Administration”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 14.3 Billion |
| Growth Rate (2024 to 2034) | 8.6% CAGR |
| Projected Value (2034F) | US$ 32.74 Billion |
The United States is approximated to account for 83.3% of the North American market revenue share by the end of 2034. The growing pool of diabetic patients along with the increasing prevalence of chronic ailments are contributing to the popularity of injection pens in homecare settings. In addition, the presence of some of the prominent suppliers of injection pens in the country is also helping the market expand. They are also used for the administration of medicines in prescribed doses of pediatric patients and infants.
“Increasing Burden of Diabetes and Expanding Healthcare Infrastructure”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 3.51 Billion |
| Growth Rate (2024 to 2034) | 9.4% CAGR |
| Projected Value (2034F) | US$ 8.62 Billion |
China is projected to hold 54.5% share of the East Asian market share by 2034-end. Growing cases of diabetes in the country along with an expansion of the healthcare infrastructure is projected to create lucrative opportunities for market players. Moreover, the willingness of more individuals to spend more on advanced therapeutics and healthcare facilities is driving demand for injection pens in China.
As mentioned in a study published by Fact.MR, a market research and competitive intelligence provider, hospitals are expected to hold 32% share of global market revenue by 2034-end. The growing inclination to hospitals for getting injection pens is attributed to the reliability of the products received.
“Pocket-friendly Prices of Reusable Pens”
| Attribute | Reusable Pens |
|---|---|
| Segment Value (2024E) | US$ 28.66 Billion |
| Growth Rate (2024 to 2034) | 7.3% CAGR |
| Projected Value (2034F) | US$ 57.87 Billion |
Reusable pens are forecasted to account for 62% share of the global market by the end of 2034. Conventional injection methods have been replaced with some more convenient and advanced options. The development of reusable injection pens is one of such improvements, which ensure accuracy in the drug delivery process. Furthermore, no cartridges are required for these injections. Users only need to replace needles therefore are considered cost-effective for medication delivery to the human body.
“Diabetic Patients Account for Leading Share of Global Market Revenue”
| Attribute | Diabetes |
|---|---|
| Segment Value (2024E) | US$ 25.99 Billion |
| Growth Rate (2024 to 2034) | 6.8% CAGR |
| Projected Value (2034F) | US$ 50.33 Billion |
Injection pens are generally used against the management and treatment of multiple diseases, including autoimmune diseases, growth hormone therapy, diabetes, and others. Among these, diabetic patients are projected to account 53.9% of global market revenue share by 2034-end. Increasing demand from the majority of diabetic patients for convenient and safer insulin delivery methods is contributing to the adoption of injection pens. Recent technological advancements in injection pens along with approvals from numerous international organizations are supporting their increased sales.
Companies operating in the global market are concentrating on expanding their footprints across regions through collaborations around the world. Multiple companies are incorporating acquisitions, mergers, and partnerships to strengthen their presence across regions. In addition, new product developments, maintaining product quality, and strengthening systems used for product supply are helping them secure a position for themselves.
Key players in the injection pen market are Novo Nordisk A/S, Sun Pharmaceutical Industries Ltd., Medtronic plc, Braun Medical, Becton, Terumo Medical Corporation, Ypsomed AG, Dickinson and Company, Owen Mumford Ltd., Hoffmann-La Roche Ltd., Sanofi, AstraZeneca, Merck, and Eli Lilly and Company.
How big is the size of the injection pen market in 2024?
The global injection pen market is estimated at US$ 46.72 billion in 2024.
What is the sales outlook for injection pens for 2034?
Global sales of injection pens are anticipated to reach US$ 93.4 billion by 2034.
At what rate is the demand for injection pens projected to increase?
The market for injection pens is forecasted to advance at a CAGR of 7.2% from 2024 to 2034.
How much share of the global market is projected to be held by reusable injection pens?
Reusable injection pens are estimated to account for 62% share of the global market by 2034-end.
At what CAGR is the demand for injection pens expected to increase in South Korea?
Sales of injection pens in South Korea are approximated to rise at a CAGR of 7.1% from 2024 to 2034.
What is the contribution of North America to the global market?
North America is evaluated to account for 36.7% share of global market revenue by 2034.
Injection Pen Market